Hypersensitivity Pneumonitis: Diagnostic and Therapeutic Challenges

Area of Science:

• Pulmonology
• Immunology
• Pathology

Background:

• Hypersensitivity pneumonitis (HP) is a prevalent interstitial lung disease (ILD) with diagnostic and therapeutic challenges.
• It arises from immune responses to inhaled antigens, leading to T-cell activation and lung inflammation.
• Genetic factors and precise pathogenic mechanisms require further elucidation.

Purpose of the Study:

• To review current understanding of hypersensitivity pneumonitis (HP).
• To highlight revised diagnostic criteria, including fibrotic and non-fibrotic classifications.
• To emphasize the need for multidisciplinary assessment and antigen identification.

Main Methods:

• Review of clinical features, diagnostic tools (HRCT, histopathology, BAL), and antigen identification challenges.
• Discussion of revised diagnostic criteria and their implications.
• Exploration of pathogenic mechanisms, including T-cell hyperactivation and fibrotic remodeling.

Main Results:

• Diagnosis relies on integrating clinical, radiological, pathological, and lavage findings, often requiring multidisciplinary input.
• Revised criteria classify HP into fibrotic and non-fibrotic types, impacting treatment and prognosis.
• Antigen removal and inflammation control are critical for disease progression.

Conclusions:

• Accurate diagnosis of HP is complex, necessitating a comprehensive, multidisciplinary approach.
• Further research into HP's molecular pathobiology is essential for novel diagnostic and therapeutic strategies.
• Targeting inflammation and identifying biomarkers are crucial for managing fibrotic HP.